Journals / Acta Medica Nicomedia / 2023 / Cilt: 6 Sayı: 3

Optimization of Protein Quantification in Wharton Jelly-Derived Mesenchymal Stem Cell Exosomes

Pages
452–458
Publication Date
2023-10-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It is predicted that these data can be used comparatively in future studies, especially for the quantification of mesenchymal stem cell exosomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Exosomes are small intracellular membrane-based vesicles with different compositions that are involved in various biological and pathological processes.
📊
Key Findings & Data:Exosomes are nanometer-sized microvesicles, approximately 30-200 nm in diameter, that contain DNA, mRNAs, non-coding RNAs, membrane proteins, and cytosolic proteins.
💡
Conclusion & Impact:Conclusion: It is predicted that these data can be used comparatively in future studies, especially for the quantification of mesenchymal stem cell exosomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Wharton Jelly · Exosome · Mesenchymal Stem Cell

Özet

Aim: Exosomes are small intracellular membrane-based vesicles with different compositions that are involved in various biological and pathological processes. They are secreted by all cell types and can be found in most body fluids, including the blood, saliva, and urine. Exosomes are nanometer-sized microvesicles, approximately 30-200 nm in diameter, that contain DNA, mRNAs, non-coding RNAs, membrane proteins, and cytosolic proteins. Mesenchymal stem cells exert paracrine effects through exosomes. Recent studies have shown that exosomes have important potential as a new alternative to cellular therapies. In this study, we aimed to obtain exosomes from Wharton-Jelly derived mesenchymal stem cells (WJ-MSCs), characterize methods, quantify protein from these exosomes, and optimize this by comparing it with the amount of nanoparticles and determining the most effective lysis solution using different lysis chemicals. Methods: For this purpose, first, WJ-MSCs' exosomes were isolated and characterized, and changes in protein levels were determined after treatment with 1 billion/ml particle exosomes with commonly used chemicals such as RIPA buffer, Mammalian Protein Extraction Reagent (M-PER), Tris-TritonX, and Tris-SDS. Results: As a result, approximately 2.5 µg/ml of 1 billion/ml particulate exosomes were detected with the BCA kit. Concentration of protein in these exosomes, and the protein concentration increased 3-4 times as a result of disintegration of the bilayer membranes in the cell membrane structure of these exosomes with RIPA buffer. Conclusion: It is predicted that these data can be used comparatively in future studies, especially for the quantification of mesenchymal stem cell exosomes.

🔖

Cite This Article

HALBUTOĞULLARI, Z. S. Ü., KORUN, Z. E. U., DEMİR, C. S., KILIÇ, K. C., ALPER, B., YAZIR, Y. (2023). Optimization of Protein Quantification in Wharton Jelly-Derived Mesenchymal Stem Cell Exosomes. Acta Medica Nicomedia, Cilt: 6 Sayı: 3, 452–458. https://ajindex.com/articles/970661

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392. doi:10.1634/stemcells.2006-0709
  2. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:1-14. doi:10.1186/1478-811X-9-12
  3. Mennan C, Wright K, Bhattacharjee A, Balain B, Richardson J, Roberts S. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed Res Int. 2013;2013:916136. doi:10.1155/2013/916136 Semenova E, Grudniak MP, Machaj EK, et al. Mesenchymal stromal cells from different parts of umbilical cord: approach to comparison & characteristics. Stem Cell Rev Reports. 2021;17(5):1780-1795. doi:10.1007/s12015-021-10157-3
  4. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev. 2006;2(2):155-162. doi:10.1007/s12015-006-0022-y Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. doi:10.1080/14653240600855905 Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L. Immunological characterization of multipotent mesenchymal stromal cells-The international society for cellular therapy (ISCT) working proposal. Cytotherapy. 2013;15(9):1054-1061. doi:10.1016/j.jcyt.2013.02.010 Batsali AK, Kastrinaki M, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther. 2013;8(2):144-55. doi:10.2174/1574888x11308020005 Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan C V. Wharton’s jelly-derived mesenchymal stem cells: Phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013;14(6):11692-11712. doi:10.3390/ijms140611692 Lai RC, Yeo RWY, Tan KH, Lim SK. Exosomes for drug delivery - A novel application for the mesenchymal stem cell. Biotechnol Adv. 2013;31(5):543-551. doi:10.1016/j.biotechadv.2012.08.008 Kooijmans SAA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM. Exosome mimetics: A novel class of drug delivery systems. Int J Nanomedicine. 2012;7:1525-1541. doi:10.2147/IJN.S29661 Schiller M, Bekeredjian-Ding I,